BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MLSC
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220519T173000
DTEND;TZID=America/New_York:20220519T193000
DTSTAMP:20260406T102253
CREATED:20220509T163252Z
LAST-MODIFIED:20220509T163252Z
UID:16446-1652981400-1652988600@www.masslifesciences.com
SUMMARY:MASS AWIS Annual Speed Networking with STEM Professionals
DESCRIPTION:It’s that time of year again! We\, at the Massachusetts Association for Women in Science (MASS AWIS)\, are very excited to host our flagship Speed Networking event. Do not miss this unique opportunity to connect virtually with professionals from various backgrounds in STEM fields. Featured fields include Industry research and Development\, Medical writing\, data science\, science communication etc. During 15-minute rounds\, you will get the chance to interact with panelists and inquire about their roles\, responsibilities\, and companies. We will be hosting this event on REMO allowing you to have the same experience as an in-person networking event! \nDisclaimer: This is NOT a career fair.\nPlease leave your resumes at home.
URL:https://www.masslifesciences.com/event/mass-awis-annual-speed-networking-with-stem-professionals/
LOCATION:Virtual Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220601T090000
DTEND;TZID=America/New_York:20220601T170000
DTSTAMP:20260406T102253
CREATED:20220209T145920Z
LAST-MODIFIED:20220209T145920Z
UID:15702-1654074000-1654102800@www.masslifesciences.com
SUMMARY:Transitioning to Leader
DESCRIPTION:Transitioning to Leader provides participants with a clear understanding of the leader-manager they aim to be and the essential skills and strategies to get them there. Approaches to effective communication and how to foster collaboration among teams (both remotely and in person) are discussed. Learn effective delegation tools to get more accomplished through direct reports. Participants will also learn the fundamentals for interviewing\, hiring\, and more. \n“Presenting ideas about communication in a different framework and using multiple examples to explain a point was the most valuable.” – Transitioning to Leader Participant\, September 2021 \nDate & Time \nWednesday\, June 1st\, 2022 9:00 AM -5:00 PM EST \nPlease plan to arrive at least 15 minutes before class starts. Class will start at 9:00 AM. We will have breaks in between. \nThis course will be held in-person. Proof of vaccination or negative COVID-19 test result (72 hours prior) will be required. All participants are required to be masked except when drinking and eating. Breakfast and lunch will be provided at this all day workshop. \nTopics \nTransitioning to Leader-Manager\nSetting Employees Up for Success\nLeader as Communicator\nFundamental Communication Skills and Responsibilities\nShaping Culture\nManager’s Role in Employee Engagement \nPlease view the discount options for courses before registering here.
URL:https://www.masslifesciences.com/event/transitioning-to-leader-2/
LOCATION:The Link\, 255 Main Street\, 8th Fl\, Cambridge\, MA\, United States
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220606T090000
DTEND;TZID=America/New_York:20220606T143000
DTSTAMP:20260406T102253
CREATED:20220215T151706Z
LAST-MODIFIED:20220215T151706Z
UID:15703-1654506000-1654525800@www.masslifesciences.com
SUMMARY:Intro to Biotech
DESCRIPTION:Intro to Biotech is a course that explores the business considerations in biotech as well as basic biological processes that are foundational to the biopharma and life sciences industry. The course is divided into two parts: Intro to Business and Intro to Science. Intro to Business provides an overview of regulation through instruction\, storytelling\, and small group sessions. Topics such as market share\, phases of development\, patient population\, and safety profile will be reviewed. Intro to Science focuses on the basics of cells and molecular biology that help students’ overall understanding of how a life science company operates. Lab work will also be implemented during in-person sessions. \nSchedule \nIntro to Business \nMonday\, June 6th\, 2022 at 12:00-2:30 PM EST\nTuesday\, June 7th\, 2022 at 12:00-2:30 PM EST\nThursday\, June 9th\, 2022 at 12:00-2:30 PM EST \nIntro to Science \nMonday\, June 13h\, 2022 at 9:00-11:30 AM EST\nTuesday\, June 14th\, 2022 at 9:00-11:30 AM EST\nThursday\, June 16th\, 2022 at 9:00-11:30 AM EST \nPlease view the discount options for courses before registering here.
URL:https://www.masslifesciences.com/event/intro-to-biotech-2/2022-06-06/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220608T083000
DTEND;TZID=America/New_York:20220608T153000
DTSTAMP:20260406T102253
CREATED:20220405T144536Z
LAST-MODIFIED:20220405T144536Z
UID:16295-1654677000-1654702200@www.masslifesciences.com
SUMMARY:2022 Life Sciences Workforce Conference
DESCRIPTION:Keys to Expanded and Diverse Talent in Life Sciences\nEducation\, Inclusion\, & Advancement\nThe 7th Annual Life Sciences Workforce Conference will focus on strategies for education\, recruitment\, inclusion\, retention\, and promotion of expanded and diverse talent for a growing industry post COVID-19. \nAttendees will be able to participate through traditional Q&A\, networking\, and facilitated Roundtable Discussions. \nDiscussion topics will include: \n\nExpanding immediate access to a pipeline of workers through training and preparation partnerships and programs\,\nAttracting diverse talent to the industry over the long-term and adjusting to a post-COVID landscape\, and\nLeveraging inclusion to retain and advance all employees.\n\nPresentations will feature: \n\nMassBioEd’s 2022 Massachusetts Life Sciences Employment Outlook\nMassBio’s Workforce Landscape Report\n\nThe MLSC is proud to sponsor this event.
URL:https://www.masslifesciences.com/event/2022-life-sciences-workforce-conference/
LOCATION:Framingham State University\, 100 State St\, Framingham\, 01701\, United States
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220608T083000
DTEND;TZID=America/New_York:20220608T153000
DTSTAMP:20260406T102253
CREATED:20220420T153619Z
LAST-MODIFIED:20220420T153619Z
UID:16398-1654677000-1654702200@www.masslifesciences.com
SUMMARY:Life Sciences Workforce Conference
DESCRIPTION:The Life Sciences Workforce Conference is uniquely devoted to bringing together the life sciences industry and academia to discuss training of the next generation of leaders. The event provides an opportunity for industry professionals and academicians to hear from other experts\, and to hold meaningful conversations about best practices for education and training\, as well as career exploration and readiness. The Conference focuses on meeting hiring needs and how industry\, government\, and academia can work together to build the best life sciences workforce in the years ahead. The MLSC is proud to sponsor this event. \nRegister using “LSWC20” discount code to receive a 20% off. Code expires on April 29th.
URL:https://www.masslifesciences.com/event/life-sciences-workforce-conference/
LOCATION:Framingham State University\, 100 State St\, Framingham\, 01701\, United States
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220609
DTEND;VALUE=DATE:20220610
DTSTAMP:20260406T102253
CREATED:20220516T171320Z
LAST-MODIFIED:20220516T171320Z
UID:16487-1654732800-1654819199@www.masslifesciences.com
SUMMARY:The Power of Partnering to Accelerate Preparedness  BLUE KNIGHT™ Symposium 2022
DESCRIPTION:Overview: On June 9\, 2022\, Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA) will host the second BLUE KNIGHT™ Symposium. Join us for a global conversation with innovators\, investors\, partners and thought leaders to discover and accelerate next-gen potential solutions for future pandemics\, emerging infectious diseases\, and other known and unknown health threats.\nBe sure to register for a full day of programming streaming virtually from JLABS @ Washington\, DC\, and other sites globally. \nAbout BLUE KNIGHT™: Blue Knight is a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA)\, part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. This collaboration aims to stimulate the innovation and incubation of science and technologies that may improve health security and response by supporting companies focused on public health threats and emerging infectious diseases. Find out more about BARDA and its mission at www.medicalcountermeasures.gov.
URL:https://www.masslifesciences.com/event/the-power-of-partnering-to-accelerate-preparedness-blue-knight-symposium-2022/
LOCATION:Online
ORGANIZER;CN="Johnson & Johnson Innovation":MAILTO:clee22@its.jnj.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220614T120000
DTEND;TZID=America/New_York:20220614T133000
DTSTAMP:20260406T102253
CREATED:20220516T171141Z
LAST-MODIFIED:20220516T171141Z
UID:16490-1655208000-1655213400@www.masslifesciences.com
SUMMARY:Bench to BARDA Panel Series - MedTech Funding
DESCRIPTION:A 6-event series describing the various opportunities to help bring your medical device technology from the bench to BARDA funding. \nAbout this event: \nThis program is a series of 6 panel discussions with industry and government partners\, focused on providing guidance and insight into how innovators can take their solution from the benchtop to the Biomedical Advanced Research & Development Authority (BARDA). BARDA is an entity within the Department of Health & Human Services that advances innovations tackling some of our nation’s greatest health security threats. This program is a collaborative effort between incubators and accelerators who are partnered with them through their Division of Research\, Innovation & Ventures (DRIVe). Each event will have its own specific focus\, while contributing to a sequential flow for the series. Experts with specific backgrounds will be asked to help provide an overview of key resources available to innovators to help fund and advance their solution from early stages of development through late stages\, as well as provide guidance on how to navigate the funding opportunities within BARDA and BARDA DRIVe. \nThis event is a collaborative event between the following BARDA accelerators and incubators: \nBiolocity\nFirst Flight Venture Center\nNew Orleans BioInnovation Center\nPurdue University\nNew York State Center for Biotechnology\nUMass M2D2\nUniversity City Science Center\nUniversity of Missouri \nTimeline and Summary \nPanel Discussion 1: BARDA Accelerator Network – Opportunities for Early-Stage Startups \nJune 14th from 12:00PM – 1:30PM EST \nThe Biomedical Advanced Research and Development Authority (BARDA) has partnered with 13 incubators and accelerators across the United States to help provide crucial resources to early-stage innovators looking to address our biggest health security threats with innovative solutions. These centers work together as a collaborative network to help DRIVe innovation from the benchtop to BARDA. During this event you will hear from key players in the network who will share more about the various resources and funding opportunities they have available to early-stage innovators to help get their solutions to more advanced stages\, there will also be time allotted for Q&A. Join us to learn more about what the BARDA Accelerator Network has to offer. \nPanel Discussion 2: I-Corps\, NSF and NIH REACH – Opportunities for Translational Research \nJune 17th from 12:00PM – 1:30PM EST \nA variety of federally funded programs are in place to assist early-stage inventors in successfully making the transition into entrepreneurship. The National Science Foundation (NSF) supports disruptive innovation with the non-dilutive SBIR/STTR program. As an earlier-phase extension of that support\, the NSF Innovation Corps (I-Corps) assists nascent groups in defining the value of their invention to society by engaging in the customer discovery process. During this event we will hear from I-Corps and NSF representatives\, and from the CEOs of startup companies who have participated in I-Corps programs and subsequently gone on to receive NSF awards. Speakers will then discuss their experiences together and take your questions. Join us to learn more about how the NSF pathway can advance your innovation. \nPanel Discussion 3: NIH SBIR/STTR & RADx \nJune 21st from 12:00PM – 1:30PM EST \nThe Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR)\, collectively the Small Business Programs\, are also known as America’s Seed Fund. By setting aside more than $1.2 billion from its Research & Development Funding specifically for Small Business Programs\, the NIH provides support to early stage small businesses throughout the nation. In 2020\, the NIH expanded their support of early stage medical innovation by launching the Rapid Acceleration of Diagnostics (RADx®) initiative to speed innovation in the development\, commercialization\, and implementation of technologies for COVID-19 testing. During this event\, you will hear from agency officials at NIH as well as entrepreneurs and researchers that have received funding through these mechanisms. Join us to learn more about accessing these resources for your medical innovation. \nPanel Discussion 4: BARDA DRIVe EZ-BAA – Overview & Funding Opportunities \nJune 24th from 12:00PM – 1:30PM EST \nThe Easy Broad Agency Announcement (EZ-BAA) is a contracting mechanism that allows BARDA to partner with early-stage product developers on smaller scale R&D projects. The EZ-BAA provides up to $750K in non-dilutive funds to accelerate innovations and improve the availability of transformative products and technologies to protect Americans from natural and intentional health security threats. During this event you will learn about the EZ-BAA and its process along with how to submit a complete abstract for the award. You will also learn about how the EZ-BAA differs from the BAA and which pathway is best suited for your company. Come learn best practices for EZ-BAA funding opportunities and hear from past EZ-BAA awardees. \nPanel Discussion 5: BARDA Broad Agency Announcement (BAA) \nJune 28th from 12:00PM – 1:30PM EST \nThe Broad Agency Announcement (BAA) is a contracting mechanism that is often used by federal agencies for the advancement of scientific studies and experimentation directed towards advancing the state-of-the-art. The BAA funding mechanism is used by BARDA to fund later-stage advanced research and development. There are a number of criteria that need to be met when completing a BAA application and leaders from across BARDA will discuss the various components and best practices for companies looking to apply for BAA funding at BARDA. \nPanel Discussion 6: Institutional Capital (VC\, CVC) \nJuly 1st from 12:00PM – 1:30PM EST \nVenture Capital is a form of private equity-based financing (including equity financing\, convertible notes\, and/or warrants) that invests in innovative promising technology in the early stages of development. The Biomedical Advanced Research and Development Authority (BARDA) works with the venture capital community to invest in promising products and technologies\, driving them to the marketplace to transform and enhance national health security. During this event you will hear from BARDA and non-BARDA VC executives who will give insight on how to appeal to and work with VC investors to help bring products and technologies to market. Join us to learn more about Venture Capital investing!
URL:https://www.masslifesciences.com/event/bench-to-barda-panel-series-medtech-funding/2022-06-14/
LOCATION:Online via Zoom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220614T130000
DTEND;TZID=America/New_York:20220614T153000
DTSTAMP:20260406T102253
CREATED:20220209T152027Z
LAST-MODIFIED:20220621T203833Z
UID:15704-1655211600-1655220600@www.masslifesciences.com
SUMMARY:Leading in a Hybrid Environment
DESCRIPTION:Leading in a Hybrid Work Environment provides leaders in life sciences with the skills and knowledge to successfully lead their teams and organizations in a hybrid work environment. The sessions will focus on the best practices that enable high performance\, engagement\, and strategic alignment for their employees. Participants learn how to adapt their leadership and people management to the unique demands of employees working both remotely and in the office. \nAgenda\nSession 1: Tuesday\, June 14th\, 2022 1:00-3:30 PM EST\nManaging for Superior Performance in a Hybrid Work Environment\nInvesting Time in Planning to Solve Challenged Connectivity\nOffering Robust Feedback and Coaching \nSession 2: Tuesday\, June 28th\, 2022 1:00-3:30 PM EST\nManaging Engagement in a Hybrid Work Environment\nBest Practices in Understanding Employees’ Needs and Interests\nHow to Leverage Employees’ Motivational Management to Increase Commitment \nSession 3: Tuesday\, July 12th\, 2022 1:00-3:30 PM EST\nMaintaining a High-Powered Hybrid Work Environment\nAssessing Team’s Performance: Resolving Any Key Gaps and Challenges \nPlease view the discount options for courses before registering.
URL:https://www.masslifesciences.com/event/leading-in-a-hybrid-environment/2022-06-14/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220617T080000
DTEND;TZID=America/New_York:20220617T170000
DTSTAMP:20260406T102253
CREATED:20220512T192042Z
LAST-MODIFIED:20220512T192042Z
UID:16444-1655452800-1655485200@www.masslifesciences.com
SUMMARY:20th Annual Cancer Research Symposium: Ten Years at the Koch Institute
DESCRIPTION:Please join us for the 20th Annual Cancer Research Symposium hosted by MIT’s Koch Institute for Integrative Cancer Research at Kresge Auditorium. Sessions and presenters include: \n—The Koch Institute on the National Stage—\nFrancis Collins\, Science Advisor to the President and Co-Chair of the President’s Council of Advisors on Science and Technology (PCAST) \nNed Sharpless\, Director of the National Cancer Institute \nMatthew Vander Heiden\, Director of the Koch Institute\nConvergent Science and Future Science \nAngela Koehler\, Associate Professor\, MIT Department of Biological Engineering and Koch Institute \nKristin Knouse\, Assistant Professor\, MIT Department of Biology and Koch Institute\nFrancisco J. Sánchez-Rivera\, Assistant Professor\, MIT Department of Biology and Koch Institute \nJoelle Straehla\, Charles W. (1955) and Jennifer C. Johnson Clinical Investigator\, Koch Institute \nYadira Soto-Feliciano\, Assistant Professor\, MIT Department of Biology and Koch Institute \nPanelists:\nSangeeta Bhatia\, John J. and Dorothy Wilson Professor of Health Sciences and Technology and of Electrical Engineering and Computer Science \nSusan Hockfield\, MIT President Emerita and Professor of Neuroscience \nPhillip A. Sharp\, Institute Professor and Professor of Biology \n—Where are they now? Welcoming back our alumni—\nShawn Davidson\, Associate Research Scholar\, Lewis-Sigler Institute for Integrative Genomics\, Princeton University \nOliver Jonas\, Assistant Professor\, Harvard Medical School; Department of Radiology\, Brigham & Women’s Hospital; Faculty\, Joint Center for Cancer Precision Medicine\, Dana-Farber Cancer Institute \nAviv Regev\, Head\, Genentech Research and Early Development\, Roche \nGiovanni Traverso\, Assistant Professor\, MIT Department of Mechanical Engineering \nPLEASE NOTE: ON-SITE REGISTRATION WILL BE VERY LIMITED—we encourage you to register in advance.\nWe strive to host inclusive\, accessible events that enable all individuals\, including individuals with disabilities\, to engage fully. To request an accommodation or for inquiries about accessibility\, please contact kievents@mit.edu
URL:https://www.masslifesciences.com/event/20th-annual-cancer-research-symposium-ten-years-at-the-koch-institute/
LOCATION:Kresge Auditorium\, Building W16\, 48 Massachusetts Avenue\, Cambridge\, MA\, 02139\, United States
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220620T090000
DTEND;TZID=America/New_York:20220620T120000
DTSTAMP:20260406T102253
CREATED:20220209T152726Z
LAST-MODIFIED:20220209T162950Z
UID:15705-1655715600-1655726400@www.masslifesciences.com
SUMMARY:Building & Managing a High Performing Team
DESCRIPTION:Building & Managing a High Performing Team is intended to help leaders at all levels in the biotech and biopharma industries improve how well they participate in and lead teams. The course focuses on principles that enhance leaders’ collaboration skills and help them to better model effective collaboration for others. Participants will consider how to address some of the typical dysfunctions and challenges that can diminish a team’s effectiveness. \nAgenda \nSession 1: Monday\, June 20th\, 2022 9:00 AM-12:00 PM EST\nCollaboration Principle: Constructive Conflict is Essential\nCollaboration Principle: Psychological Safety Matters\nCollaboration Principle: Seek Win-Win\nCollaboration Principle: Balance Advocacy & Inquiry\nLeader as Collaborator \nSession 2: Monday\, June 27th\, 2022 9:00 AM-12:00 PM EST\nHigh Performing Teams – Success Factors\nBuilding a New Team\nStages of Team Development\nLeader as Lynchpin\nStakeholder Management \nSession 3: Monday\, July 11th\, 2022 9:00 AM-12:00 PM EST\nThe 5 Dysfunctions of a Team\nDisagree & Commit\nFostering a One-Team Culture\nLeader as Teambuilder \nSession 4: Monday\, July 18th\, 2022 9:00 AM-12:00 PM EST\nMaximizing Team Performance\nMeeting Effectiveness\nFramework for Continuous Team Improvement \nPlease view the discount options for courses before registering here.
URL:https://www.masslifesciences.com/event/building-managing-a-high-performing-team-2/2022-06-20/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220621
DTEND;VALUE=DATE:20220623
DTSTAMP:20260406T102253
CREATED:20220112T142943Z
LAST-MODIFIED:20220121T133117Z
UID:15517-1655769600-1655942399@www.masslifesciences.com
SUMMARY:LSX World Congress USA 2022
DESCRIPTION:LSX World Congress USA will replicate the unique dynamics and high-quality senior audience that has become the hallmark of LSX events around the world. In June 2022\, we’ll be gathering North America’s leading Biotech\, Medtech and HealthTech CEOs for a 2-day executive conference\, 1-2-1 in-person partnering and showcase opportunities. \nLSX is an influential community of senior life science & healthcare decision-makers. We connect senior life science & healthcare executives with access to the capital\, intelligence\, innovation\, and partners they need to grow their businesses. We achieve this through a programme of high-level conferences and networking events\, via content that showcases and shares the expertise of senior leaders and industry stakeholders\, as well as through bespoke initiatives. \nUse code ‘MLSC15’ for 15% off your ticket.
URL:https://www.masslifesciences.com/event/lsx-world-congress-usa-2022/
LOCATION:Hynes Convention Center\, 900 Boylston Street\, Boston\, MA\, United States
ORGANIZER;CN="LSX":MAILTO:marketing@lsxleaders.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220623T120000
DTEND;TZID=America/New_York:20220623T130000
DTSTAMP:20260406T102253
CREATED:20220608T221555Z
LAST-MODIFIED:20220608T221555Z
UID:16620-1655985600-1655989200@www.masslifesciences.com
SUMMARY:SBIR/STTR Grant Lunch and Learn
DESCRIPTION:Is The SBIR/STTR Program right for you? Find out how you could receive amazing grant funding! \nThe SBIR/STTR program is a federal grant and contracting program that awards more than $3 billion a year to small businesses to support the commercialization of innovative technology. \nAre you missing out on this great opportunity? \nJoin SBIR/STTR consultant Kris Parmelee for a FREE lunch and learn opportunity that will provide an introductory overview to this complex and highly competitive program. \nSign up to learn more!
URL:https://www.masslifesciences.com/event/sbir-sttr-grant-lunch-and-learn/
LOCATION:110 Canal St\, 110 Canal St\, Lowell\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220623T120000
DTEND;TZID=America/New_York:20220623T130000
DTSTAMP:20260406T102253
CREATED:20220622T132824Z
LAST-MODIFIED:20220622T132824Z
UID:16676-1655985600-1655989200@www.masslifesciences.com
SUMMARY:The Secret Sauce: Tips & Tricks for a Successful BLUE KNIGHT™ QuickFire Challenge: Next-Generation Preparedness Solutions Application
DESCRIPTION:Join us for an Information Session about the BLUE KNIGHT™ QuickFire Challenge. Ahead of the submission deadline approaching on July 22nd\, attendees will have an opportunity to: \n• Learn more about the Challenge’s key focus areas related to infectious disease\, immunology\, & the microbiome (more details below)\n• Get the inside scoop on what makes an applicant stand out\n• Learn the do’s and don’ts for submissions\n• Ask questions to experts from Johnson & Johnson Innovation and BARDA \nAbout the Challenge: \nNew infectious diseases have been emerging with increased frequency\, furthering the likelihood of another pandemic or serious health threat occurring during our lifetime – potentially as soon as within the next decade.1 In today’s interconnected world\, there is a greater need to work together to spark potential solutions for tomorrow’s known and unknown public health threats. New innovations\, particularly those with multi-use potential\, are needed to help rapidly and efficiently respond to emerging health security threats and infectious diseases. \nBLUE KNIGHT™\, a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA)\, part of the Office of the Assistant Secretary for Preparedness Response (ASPR) at the U.S. Department of Health and Human Services (HHS)\, seeks to answer this call by anticipating potential health security threats\, activating the global innovation community\, and amplifying scientific and technological advancements. That’s why Johnson & Johnson Innovation\, together with BARDA\, launched the BLUE KNIGHT™ QuickFire Challenge: Next-Generation Preparedness Solutions Application. \nInnovators developing potentially ground-breaking ideas or technologies that aim to enhance preparedness solutions towards future known and unknown infectious disease threats are invited to submit ideas for up to $200\,000 in total award funding and access to the global Johnson & Johnson Innovation – JLABS network through Blue Knight residency with mentorship from experts at the Johnson & Johnson Family of Companies and BARDA. Innovators must be developing potential preparedness solutions addressing at least one of the following QuickFire Challenge focus areas: \n-Targeting the host response to known and unknown future infectious disease threats\n-Enabling streamlined manufacturing of therapeutics and/or vaccines\n-Leveraging the host microbiome
URL:https://www.masslifesciences.com/event/the-secret-sauce-tips-tricks-for-a-successful-blue-knight-quickfire-challenge-next-generation-preparedness-solutions-application/
LOCATION:Virtual Event
ORGANIZER;CN="Johnson & Johnson Innovation":MAILTO:clee22@its.jnj.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220624T080000
DTEND;TZID=America/New_York:20220624T160000
DTSTAMP:20260406T102253
CREATED:20220527T192609Z
LAST-MODIFIED:20220527T192609Z
UID:16581-1656057600-1656086400@www.masslifesciences.com
SUMMARY:USA-India Chamber of Commerce 16th annual BioPharma & Healthcare Summit
DESCRIPTION:USAIC’s annual BioPharma & Healthcare Summit is a top industry event for senior executives focused on Drug Discovery & Development\, Partnering\, Licensing\, External Research\, Translational Research\, Clinical Trails\, Data & Digital Sciences\, Medical Devices\, Healthcare\, Innovation and Emerging Markets. \nThe virtual event will be chaired by Andrew Plump\, President of R&D\, Takeda Pharmaceuticals\, and will feature talks from speakers such as Alex Gorsky\, Executive Chairman\, Johnson & Johnson and Lawrence Tabak\, Acting Director\, NIH. Topics will include R&D strategies and trends\, digital & data science in healthcare and more. \nRegistration is complimentary\, though seats are limited. Register online!
URL:https://www.masslifesciences.com/event/usa-india-chamber-of-commerce-16th-annual-biopharma-healthcare-summit/
LOCATION:Virtual Event
ORGANIZER;CN="USA-India Chamber of Commerce":MAILTO:https://usaindiachamber.org/index.php
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220628T084500
DTEND;TZID=America/New_York:20220628T160000
DTSTAMP:20260406T102253
CREATED:20220608T221410Z
LAST-MODIFIED:20220608T221410Z
UID:16625-1656405900-1656432000@www.masslifesciences.com
SUMMARY:Free Symposia: Unlocking High-Throughput Biology
DESCRIPTION:Please join Carterra at our upcoming symposium in Boston\, MA. You will spend the day learning about high-throughput drug discovery and antibody therapeutics with some of the industry’s leading scientists. Our speakers will present new ways of looking at discovery\, applications\, and workflows\, including HT-SPR. The topics you’ll hear about include: \n– Antibody discovery in 90 days! Screening\, identification & characterization\n– New methods in DELs\, PROTACs and other formats\n– New technology and innovations during the pandemic\n– Data analysis routines & automation\n– Best practices in analyzing SPR data \nNetwork with your peers. Lunch will be provided. Registration is required as seating is limited.
URL:https://www.masslifesciences.com/event/free-symposia-unlocking-high-throughput-biology/
LOCATION:Le Meridien Cambridge\, 20 Sidney Street\, Cambridge\, MA
ORGANIZER;CN="Carterra":MAILTO:questions@carterra-bio.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220629T090000
DTEND;TZID=America/New_York:20220629T110000
DTSTAMP:20260406T102253
CREATED:20220623T160948Z
LAST-MODIFIED:20220623T160948Z
UID:16727-1656493200-1656500400@www.masslifesciences.com
SUMMARY:MassEcon Spotlight Series: Greater Boston Region Spotlight
DESCRIPTION:As MassEcon focuses on marketing Massachusetts beyond its borders\, we invite you to this Spotlight Series discussion. Join us for: \n\n\nHigh-level snapshot of industry trends in the area\nInteractive Roundtable Discussion: Why Greater Boston works as a business location\n\n\nAgenda: \n\n8:30 am: Registration\n9 am: Welcome and Introductions\n9:10 am: An Economic Overview of Greater Boston: Trends\, Advantages\, Competition\n9:45 am: Moderated Panel Discussion: What are the competitive Advantages of the Greater Boston region as a location for businesses\n10:30 am: Audience Q&A\n10:55 am: Wrap-up Remarks\n11:00 am: Event Close
URL:https://www.masslifesciences.com/event/massecon-spotlight-series-greater-boston-region-spotlight/
LOCATION:MassBio\, 700 Technology Square 5th Floor\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220629T160000
DTEND;TZID=America/New_York:20220629T190000
DTSTAMP:20260406T102253
CREATED:20220608T221523Z
LAST-MODIFIED:20220608T221523Z
UID:16621-1656518400-1656529200@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-9/
LOCATION:MA
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220707T160000
DTEND;TZID=America/New_York:20220707T180000
DTSTAMP:20260406T102253
CREATED:20220624T171832Z
LAST-MODIFIED:20220624T171832Z
UID:16729-1657209600-1657216800@www.masslifesciences.com
SUMMARY:Career Pathways in Biotech
DESCRIPTION:Join us for networking and hear from a panel of professionals across the industry to uncover the career possibilities that exist in biotech \nAbout this event: \nLabCentral Ignite is pleased to welcome a diverse group of interns who are spending their summer working in the Boston-Cambridge biotech industry. \nAttendees will hear from a panel of professionals who will share their journeys into biotech\, the experiences that got them there\, and a little about their day-to-day work. There will also be opportunities for networking and discussion. Refreshments will be served and we encourage interns to invite their supervisors to join\, as well! \nPanelists include: \nTendai Chisowa\, Hummingbird VC \nMichelle Lira\, New England Biolabs \nSusannah Calhoun\, Parthenon Therapeutics \nJuan Patarroyo\, LabCentral \nUzo Erlingsson\, LEAS Lab \nNote: We will follow LabCentral’s COVID-19 safety protocols that are in place at the time of the event. Masks will likely be required for this event.
URL:https://www.masslifesciences.com/event/career-pathways-in-biotech/
LOCATION:LabCentral 238\, 238 Main Street 6th Floor\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220720T160000
DTEND;TZID=America/New_York:20220720T200000
DTSTAMP:20260406T102253
CREATED:20220627T160453Z
LAST-MODIFIED:20220627T160453Z
UID:16697-1658332800-1658347200@www.masslifesciences.com
SUMMARY:M2D2 IMPACT Cycle 3 Accelerator Pitch-Off
DESCRIPTION:Hear ten medical device startups selected for the IMPACT Accelerator Program pitch their innovation to a panel of industry experts. \nJoin Massachusetts life sciences community as the startups from the Cycle 3 Cohort pitch their medical device solution to a panel of judges. These startups are working with M2D2 and Hologic to advance the commercialization of their innovation through the IMPACT Accelerator Program.
URL:https://www.masslifesciences.com/event/m2d2-impact-cycle-3-accelerator-pitch-off/
LOCATION:110 Canal St\, 110 Canal St\, Lowell\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220721T090000
DTEND;TZID=America/New_York:20220721T190000
DTSTAMP:20260406T102253
CREATED:20220630T171958Z
LAST-MODIFIED:20220630T171958Z
UID:16754-1658394000-1658430000@www.masslifesciences.com
SUMMARY:MALSI DAY 2022
DESCRIPTION:Now in its 15th year\, Massachusetts Life Sciences Innovation (MALSI) Day brings scientific leaders\, post-docs\, professors\, entrepreneurs\, innovators\, and venture capitalists to celebrate the most important day for life sciences startups and innovation in the Commonwealth of Massachusetts. \nThis year’s exciting program and speakers will showcase Creating the New Normal: Life In The Fast Lane. The agenda includes keynote presentations\, panel discussions\, an emerging technology poster competition\, an innovators’ marketplace\, networking opportunities with leading life sciences CEOs\, and more! \nMALSI is presented by Innovation Studio in partnership with MassVentures\, and all the major organizations involved in starting and supporting the life sciences startup ecosystem in the Commonwealth.
URL:https://www.masslifesciences.com/event/malsi-day-2022/
LOCATION:District Hall Boston\, 75 Northern Avenue\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Innovation Studio":MAILTO:press@innovationstudio.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220725T120000
DTEND;TZID=America/New_York:20220725T130000
DTSTAMP:20260406T102253
CREATED:20220722T191732Z
LAST-MODIFIED:20220722T191732Z
UID:16862-1658750400-1658754000@www.masslifesciences.com
SUMMARY:Women Leadership in Biotech Summer Webinar Series
DESCRIPTION:In this four-part webinar series\, women leaders will speak about their career journeys and offer advice around the challenges and opportunities in navigating a biotech career. This free webinar series is designed primarily for women leaders at all levels\, but all are welcome. \nThe 2022  topics include: \n\nAddressing Imposter Syndrome in Biotech Leadership and How to Mitigate it\nThe Founder’s Journey: A Guide to Starting a Biotech\n\nJuly 25\, 2022  | 12:00 – 1:00 pm ET\nTwo extraordinary biotech founders Dr Pamela Contag and Dr Jo Viney\, together with moderator Dr Anna Frostegård\, share their journeys building biotech companies\, from initial inception\, investment\, development through to IPO. They will discuss key aspects of building a biotech\, challenges\, and what they wish they had known before embarking on their founders journey.\n\n\nNow that You Have a Seat on the Board\, What to Expect and How to Influence\n\nAugust 3\, 2022  | 12:00 – 1:00 pm ET\nThe board of directors play an essential role in assessing the overall direction and strategy of a business. In this webinar we address what to expect and how to influence as a board member. More specifically:  \n\nHow to break in once you’re on the board?\nHow you operate once you’re on the board\nKey pieces of advice\nHow do you ensure that you pave the way for future women on the board\nAddressing DEI\n\n\n\n\nHow to be Proactive as a Networker\n\nAugust 17\, 2022  | 12:00 – 1:00 pm ET\nWe all know that networking is essential in building a community\, ideas and actions. Networking can at times require a strategic and creative approach. It can also require planning and most certainly stepping outside one’s comfort zone. In this webinar\, our group of experienced biotech executives share best practices on how to be a more effective networker and how to maximize networking opportunities. In addition\, we also address: \n\nHow to evaluate women networking groups\nA look at traditional male networking\nHow to seek out people who can amplify your opportunity to build your personal brand and network\nCase examples
URL:https://www.masslifesciences.com/event/women-leadership-in-biotech-summer-webinar-series/2022-07-25/
LOCATION:Online\, online
ORGANIZER;CN="Conference Forum":MAILTO:service@tcfllc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220727T160000
DTEND;TZID=America/New_York:20220727T190000
DTSTAMP:20260406T102253
CREATED:20220721T144028Z
LAST-MODIFIED:20220721T144028Z
UID:16839-1658937600-1658948400@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-10/
LOCATION:MA
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220825T100000
DTEND;TZID=America/New_York:20220825T120000
DTSTAMP:20260406T102253
CREATED:20220822T210221Z
LAST-MODIFIED:20220822T210221Z
UID:17059-1661421600-1661428800@www.masslifesciences.com
SUMMARY:Engineering strategies for improving adoptive T cell therapy against cancer
DESCRIPTION:The adoptive cell transfer (ACT) of tumor-specific T cells has emerged as a potent treatment against some advanced cancers. For example\, ACT of ex vivo expanded tumor-infiltrating lymphocytes (TILs) has achieved durable and complete responses in about 20% of melanoma patients receiving a single transfusion. In addition\, TCR-redirected T cells targeting the cancer testis antigen NY-ESO-1157-165 have shown important clinical promise against melanoma\, myeloma\, and synovial sarcoma. Furthermore\, ACT with peripheral blood T cells gene-modified to express chimeric antigen receptor (CAR) T cells targeting the B-cell lineage antigen CD19 has led to complete remission for up to 90% of some advanced\, treatment-refractory hematological cancer patients. \nHowever\, unprecedented responses to CAR therapy have not been achieved against epithelial-derived solid tumors\, the most common category of cancers. Indeed\, solid tumors present a variety of barriers to CAR therapy\, including that there is a lack of tumor antigens not also found on healthy tissues\, thus running the risk of on-target but off-tumor toxicity. Hence\, both TCR- and CAR T cells face various immunosuppressive barriers in the solid tumor microenvironment (TME)\, which can be detrimental to their persistence and function. \nCreative Biolabs has invited Dr. Melita Irving to join us in this webinar section and discuss the latest findings of her research team on an innovative CAR design\, hoping to provide insights into the engineering strategies for improving the efficacy and safety of CAR and TCR cell therapies against cancer. \nDuring this webinar\, the following topics will be discussed: \nThe use of syngeneic tumor models to evaluate the ability of co-engineered murine CAR T cells to reprogram the TME and boost T cell function\nThe use of low doses of irradiation to inflame cold tumors and render them responsive to rational combinatorial immunotherapy\nThe novel STOP-CAR integrates efficacy and safety directly into CAR design
URL:https://www.masslifesciences.com/event/engineering-strategies-for-improving-adoptive-t-cell-therapy-against-cancer/
LOCATION:Virtual
ORGANIZER;CN="Creative Biolabs":MAILTO:marketing@creative-biolabs.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220829T090000
DTEND;TZID=America/New_York:20220830T220000
DTSTAMP:20260406T102253
CREATED:20220804T125625Z
LAST-MODIFIED:20220804T125625Z
UID:16927-1661763600-1661896800@www.masslifesciences.com
SUMMARY:Nucleate Summit 2022
DESCRIPTION:The Nucleate Summit will be hosted in Boston\, Massachusetts on August 29-30. \nThe two-day celebration will unify Nucleate’s worldwide community in person for the first time\, connecting hundreds of volunteers\, founders\, and investors. \nThe Leadership Summit (Day 1) includes shared experiences that will strengthen bonds among Nucleate leadership\, alumni\, special guests\, and sponsors. It will also invite participants to explore the city of Boston and its advanced biotech ecosystem. Here\, the action will be off-stage: attendees will form deep connections with biotech leaders and Nucleate’s partners. \nThe Community Summit (Day 2) includes premier networking opportunities\, inspirational speakers\, and the Activator Pitch Showcase\, features recent winners from the 9 Nucleate regions. Many other teams from the Activator 2022 cohort will also attend; they are building on $9 million in funding raised in just the past few weeks.
URL:https://www.masslifesciences.com/event/nucleate-summit-2022/
LOCATION:Royale\, 279 Tremont St\, Boston\, 02116\, United States
ORGANIZER;CN="Nucleate":MAILTO:contact@nucleate.xyz
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220831T160000
DTEND;TZID=America/New_York:20220831T190000
DTSTAMP:20260406T102253
CREATED:20220816T174559Z
LAST-MODIFIED:20220816T174559Z
UID:17043-1661961600-1661972400@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-11/
LOCATION:Virtual
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260406T102253
CREATED:20220711T131347Z
LAST-MODIFIED:20220711T131347Z
UID:16792-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Pharmacology – Essentials
DESCRIPTION:HMX Pro Pharmacology – Essentials covers the basic concepts required to understand the field of pharmacology today\, with an emphasis on the principles that describe what the body does to a drug and in turn what a drug does to the body.
URL:https://www.masslifesciences.com/event/pharmacology-essentials/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260406T102253
CREATED:20220711T131427Z
LAST-MODIFIED:20220711T131427Z
UID:16791-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Drug Discovery and Development
DESCRIPTION:With all the advances in science and with closer collaboration between different scientific disciplines\, a multifaceted approach is now being applied to drug discovery and development. Therefore\, learning about the process of drug discovery and development has important implications for anyone working in health care and related sectors. \nThis advanced course offers a unique way for professionals to learn from leading Harvard Medical School faculty about how drugs are developed and about the advances happening in this field that are ultimately helping to improve the treatment and prevention of disease.
URL:https://www.masslifesciences.com/event/drug-discovery-and-development/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260406T102253
CREATED:20220711T131503Z
LAST-MODIFIED:20220711T131503Z
UID:16790-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Drug Delivery
DESCRIPTION:The range of systems and approaches that can be used to deliver therapeutics is growing and advancing at an incredible rate\, so learning about the advances in drug delivery has important implications for anyone working in health care and related sectors. \nThis online course offers a unique way for professionals to learn from leading Harvard Medical School faculty about cutting-edge drug delivery systems and approaches that can be used in the treatment and prevention of disease.
URL:https://www.masslifesciences.com/event/drug-delivery/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260406T102253
CREATED:20220711T131559Z
LAST-MODIFIED:20220711T131559Z
UID:16789-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Vaccines and Viral Immunology
DESCRIPTION:Viral infections are responsible for many human diseases\, from common diseases like the flu to emerging infections such as Zika virus and SARS-CoV-2. \nUnderstanding how the immune system works to prevent and remove viral infections is essential for anyone working to develop or distribute vaccines that can protect against these diseases. \nThis advanced course offers a unique way for professionals to learn from leading Harvard Medical School faculty about cutting-edge developments in the creation of vaccines to protect against viral infections.
URL:https://www.masslifesciences.com/event/vaccines-and-viral-immunology/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220906
DTEND;VALUE=DATE:20221119
DTSTAMP:20260406T102253
CREATED:20220711T131632Z
LAST-MODIFIED:20220711T131632Z
UID:16788-1662422400-1668815999@www.masslifesciences.com
SUMMARY:Novel Therapies for Chronic Inflammation\, Autoimmunity\, and Allergy
DESCRIPTION:Advances in our knowledge of the immune system are uncovering connections between inflammation and many different diseases. \nUnderstanding how the immune system is activated and regulated is essential for anyone working to develop treatments for autoimmunity\, chronic inflammation\, and allergy\, or to apply these treatments in the clinic. \nThis online course offers a unique way for professionals to learn from leading Harvard Medical School faculty about cutting-edge therapies to treat chronic inflammation and related diseases.
URL:https://www.masslifesciences.com/event/novel-therapies-for-chronic-inflammation-autoimmunity-and-allergy/
LOCATION:Online\, online
END:VEVENT
END:VCALENDAR